Article
IDE (rs6583817) polymorphism and type 2 diabetes differentially modify executive function in older adults.
Neurobiology of aging - 1 Sept 2013
McFall G Peggy, Wiebe Sandra A, Vergote David, Westaway David, Jhamandas Jack, Dixon Roger A
Abstract excerpt
We tested independent and interactive contributions of a recently noted and promising insulin degrading enzyme polymorphism (IDE; rs6583817) and type 2 diabetes (T2D) to executive function performance, concurrently and longitudinally. Regarding normal neurocognitive decline and Alzheimer's disease, T2D is a known risk factor and this IDE variant might contribute risk or risk reduction via the minor (A) or major...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
